MicroRNA-206 Downregulation Improves Therapeutic Gene Expression and Motor Function in mdx Mice
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disorder caused by a mutation in the dystrophin gene. Numerous gene therapies have been developed to replace or repair the defective dystrophin gene; however, these treatments cannot restore the full-length protein or completely resolve dy...
Main Authors: | Karen Bulaklak, Bin Xiao, Chunping Qiao, Jianbin Li, Tejash Patel, Quan Jin, Juan Li, Xiao Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-09-01
|
Series: | Molecular Therapy: Nucleic Acids |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253118301082 |
Similar Items
-
A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice
by: Quan Jin, et al.
Published: (2019-05-01) -
The Roles of microRNA-206 in Gastric Cancer Progression
by: Pei-Chen Li, et al.
Published: (2013) -
MicroRNA-206 Controls Muscle Development in Zebrafish Embryos through Silencing Novel MicroRNA-206-Specific Target Genes
by: Wen-Yen Chang, et al.
Published: (2011) -
Downregulation of MicroRNA-206 Alleviates the Sublethal Oxidative Stress-Induced Premature Senescence and Dysfunction in Mesenchymal Stem Cells via Targeting Alpl
by: Xuan Liu, et al.
Published: (2020-01-01) -
Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer
by: Cheng-Gong Hou, et al.
Published: (2016-09-01)